Dr. Amanda Reiman conducted one of the first research studies on medical cannabis patients using cannabis as a substitute for alcohol and other drugs.
Surveying medical cannabis patients at the Berkeley Patient’s Group, her research reveals that many are using cannabis to help manage pain and mental health issues, often choosing it over alcohol, tobacco, and non-prescribed drugs. Her findings challenge conventional thinking and open up important conversations about substance use, addiction, and the potential role of cannabis in public health and policy.
This week we sit down with Dr. Amanda Reiman to discuss the following:
- Cannabis as a hard reduction tool
- Substitute Alcohol
- THC tolerance break
- Cannabis Risks
About Dr. Amanda Reiman
Amanda Reiman, PhD is the Chief Knowledge Officer for New Frontier Data, a data and insights company serving the legal cannabis industry. She has been studying cannabis use as it relates to human behavior and greater society for over twenty years.
Dr. Reiman earned her PhD in Social Welfare from the University of California and conducted one of the first research studies on medical cannabis patients and the use of cannabis as a substitute for alcohol and other drugs. An internationally recognized cannabis expert and public health researcher. Dr. Reiman has presented her research all over the world. She has written for/been quoted in The Huffington Post, New York Times, Washington Post, and Rolling Stone as well as numerous peer reviewed academic journals and several textbooks. She currently sits on the Board of the National Cannabis Roundtable and the Industrial Advisory Committee for Excelsior College’s Cannabis Program.
Follow us: Our Links.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain
🎥 YouTube: The Dime
📸 Instagram: The Dime